Seeing Clearly: Navigating Ocular Toxicities in Chemotherapy

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 45 Minutes

Overview

Enhancing understanding of ocular toxicities associated with chemotherapy is crucial for effective patient care. This course focuses on the clinical implications of ocular side effects from chemotherapy agents like BRAF/MEK inhibitors, immune checkpoint inhibitors, and antibody-drug conjugates. Participants will learn to identify and manage common ocular adverse effects supported by evidence-based monitoring protocols and patient education strategies. The training will emphasize early symptom recognition, the implementation of suitable management strategies, and the value of a multidisciplinary approach to optimize patient outcomes.  

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Identify common ocular toxicities associated with various chemotherapy agents and clinical significance in patient care.
  2. Describe appropriate monitoring protocols and patient education for ocular health in chemotherapy patients.
  3. Discuss comprehensive management and intervention strategies for patients experiencing ocular toxicities.                                                                                       
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 0.75 credit.
Course opens: 
04/28/2025
Course expires: 
04/28/2026
Cost:
$0.00
Rating: 
0

Faculty

Miranda Benfield, PharmD, BCOP

Dr. Miranda Benfield is a dedicated Gynecologic Oncology Pharmacist with a passion for mentoring and advancing the field of cancer care. After completing her undergraduate studies at NC State University and Doctor of Pharmacy degree from Wingate University School of Pharmacy, she pursued her residency training at Atrium Health's Carolinas Medical Center/Levine Cancer Institute, where she served as a PGY1 and PGY2 resident. Following her residency, she stayed on as a Gyn Oncology Pharmacist, focusing on patient care and education. With expertise in gestational trophoblastic neoplasms, endometrial cancer, and advanced cervical cancer, Dr. Benfield is committed to staying at the forefront of her field. Outside of work, she enjoys traveling, golfing, and spending time with her husband Corey and beloved dog Lizzie.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Miranda Benfield, PharmD, BCOP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 0.75 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above